Natural Product Drug Delivery Methods for Oncology

Authors

  • Kadriye Ozlem Saygi Department of Chemistry, Faculty of Arts and Sciences, Vocational School, Tokat Gaziosmanpasa University, 60250 Tokat, Turkey.

Keywords:

natural products, drug discovery, drug delivery systems, nanoparticles

Abstract

Growing interest in natural anticancer therapies has been noted in recent decades, primarily as a result of unresolved medication resistance issues. Many in vitro and in vivo studies have shown how natural chemicals can inhibit tumour growth by affecting various cellular processes and signalling pathways. By improving the bioavailability and in vivo stability, lowering side effects, and enhancing target-specific activity, the incorporation converting organic materials into various delivery methods may significantly improve their anticancer efficacy. The research works that relate to nanostructured systems with natural substances for innovative drug delivery methods in anticancer therapy will be the main emphasis of this review. These systems have the potential to overcome many of the limitations of traditional drug delivery methods, such as poor solubility and stability, low bioavailability, and variable pharmacokinetics. They can also give specific delivery of the affected area while minimizing the side effects. Therefore, it is essential to recognize the possibilities of nanostructured medication delivery methods provide some safe and effective cancer-treatment methods patients. Nanostructured medication delivery methods can improve drug solubility, bioavailability, and consistency, and also provide controlled and targeted the drug's release to the affected area. This would reduce the amount of drug needed, making it more cost-effective, and decrease the side effects of the drugs. As such, these systems could provide a more effective treatment for cancer patients. Nanostructured drug delivery systems could revolutionize the way cancer is treated, and improve patient outcomes. Furthermore, such systems could be used in other applications, such as targeted release of other therapeutic agents. Nevertheless, moreover, potential drawbacks to using nanostructured medication delivery mechanisms. One such drawback is that These devices are still in the initial stages of development, and have not yet been proven to be effective. Additionally, there is a risk that the drugs delivered by these systems could be toxic, and cause side effects. Keywords: natural products: drug discovery: drug delivery systems, nanoparticles

 

 

Author Biography

Kadriye Ozlem Saygi, Department of Chemistry, Faculty of Arts and Sciences, Vocational School, Tokat Gaziosmanpasa University, 60250 Tokat, Turkey.

 

 

References

Sitki Copur M. State of cancer research around the globe. Oncology. 2019 May 1;33(5):(08909091).

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015 Jan 5;65(1):5-29. doi: 10.3322/caac.21254, PMID 25559415.

Macpherson L.M.D. Raising awareness of oral cancer from a public and health professional perspective. Br Dent J. 2018 Nov 9;225(9):809-14. doi: 10.1038/sj.bdj.2018.919, PMID 30412572.

Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Syst Pharm. 2009 Aug 15;66(16):1471-7. doi: 10.2146/ajhp080238, PMID 19667004.

Wall ME, Wani MC. Camptothecin and taxol: discovery to clinic–thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 1995;55(4):753-60. PMID 7850785.

Wall ME. Camptothecin and Taxol: discovery to clinic. Med Res Rev. 1998 Sep;18(5):299-314. doi: 10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o, PMID 9735871.

Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019 Apr 11;133(15):1630-43. doi: 10.1182/blood-2019-01-894980.

Martino E, Della Volpe S, Terribile E, Benetti E, Sakaj M, Centamore A et al. The long story of camptothecin: from traditional medicine to drugs. Bioorg Med Chem Lett. 2017 Feb 15;27(4):701-7. doi: 10.1016/j.bmcl.2016.12.085, PMID 28073672.

Oberlies NH, Kroll DJ. Camptothecin and Taxol: historic achievements in natural products research. J Nat Prod. 2004 Feb 27;67(2):129-35. doi: 10.1021/np030498t, PMID 14987046.

Available from: https://sci-hub.hkvisa.net/10.1007/s13659-020-00293-7 [cited 25/3/2023] (include some sentences from the subheading “Natural Products in Clinical Cancer Treatment: The Glory in the History”.

Detsi A, Kavetsou E, Kostopoulou I, Pitterou I, Pontillo A.R.N., Tzani A et al. Nanosystems for the encapsulation of natural products: the case of chitosan biopolymer as a matrix. Pharmaceutics. 2020;12(7):669. doi: 10.3390/pharmaceutics12070669, PMID 32708823.

Ntohogian S, Gavriliadou V, Christodoulou E, Nanaki S, Lykidou S, Naidis P et al. Chitosan nanoparticles with encapsulated natural and uf-purified annatto and saffron for the preparation of uv protective cosmetic emulsions. Molecules. 2018;23(9):2107. doi: 10.3390/molecules23092107, PMID 30131464.

Raghukumar S, Raghukumar S. The marine environment and the role of fungi. Fungi Coast Ocean Mar Ecosyst Mar Fungi. 2017:17-38.

Stahl W, Heinrich U, Jungmann H, Sies H, Tronnier H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am J Clin Nutr. 2000;71(3):795-8. doi: 10.1093/ajcn/71.3.795, PMID 10702175.

Lin LG, Xie H, Li HL, Tong LJ, Tang CP, Ke CQ et al. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening. J Med Chem. 2008 Aug 14;51(15):4419-29. doi: 10.1021/jm701501x, PMID 18610999.

Yang SP, Zhang XW, Ai J, Gan LS, Xu JB, Wang Y et al. Potent HGF/c-Met axis inhibitors from Eucalyptus globulus: the coupling of phloroglucinol and sesquiterpenoid is essential for the activity. J Med Chem. 2012 Sep 27;55(18):8183-7. doi: 10.1021/jm3007454, PMID 22934600.

Li MH, Miao ZH, Tan WF, Yue JM, Zhang C, Lin LP et al. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1α by promoting proteasome-mediated degradation. Clin Cancer Res. 2004 Dec 15;10(24):8266-74. doi: 10.1158/1078-0432.CCR-04-0951, PMID 15623602.

Published

13-03-2023

How to Cite

Saygi, K. O. “Natural Product Drug Delivery Methods for Oncology”. International Journal of Trends in OncoScience, vol. 1, no. 1, Mar. 2023, pp. 1-7, https://www.ijtos.com/index.php/journal/article/view/2.

Issue

Section

Review Articles